| |
PATRICK J. SINKO, Ph.D., RPh, FAAPS
Patrick Sinko is Professor II (Pharmaceutics) and holds the Parke-Davis Endowed Chair in Pharmaceutics and Drug Delivery in the Ernest Mario School of Pharmacy at Rutgers - The State University of New Jersey. He also serves as the Chairman of the Department of Pharmaceutics, a position he has held since 1998. At Rutgers, the rank of Professor II is a distinguished academic rank above full professor awarded to professors who have achieved international recognition for scholarly eminence and outstanding achievement within and outside of the University.
He is a Pharmacist (BS, Rutgers, 1982) and a Pharmaceutical Scientist (PhD, Pharmaceutics, University of Michigan, 1988). From 1988-1991, he held a joint appointment at the University of Michigan and TSRL, Inc. Dr. Sinko has risen through the academic ranks since joining Rutgers in 1991.
Dr. Sinko’s research program focuses on biopharmaceutics and drug delivery with specific applications to AIDS, Cancer, and Chemical Terrorism Countermeasures. He is an accomplished researcher and scholar having published more than 300 book chapters and peer-reviewed papers and abstracts. He also has seven issued and numerous pending patents. Since joining Rutgers he has obtained nearly $14 million in total research funding as a Principal Investigator from a variety of sources including continuous funding from the NIH since 1992. Dr. Sinko is a Fellow in the American Association of Pharmaceutical Scientists (2003) and is a co-founder of two companies NaviCyte, Inc. and TheraPort Biosciences. He is also a member of the New Jersey Center for Biomaterials, the Cancer Institute of New Jersey, the Environmental Occupational Health Safety Institute, and the NSF/NCI IGERT program in NanoPharmaceutical Engineering.
Professor Sinko is an active teacher in the Pharm.D. and Pharmaceutical Science, Toxicology, and Biomedical Engineering Graduate Programs. He has trained 16 MS and PhD students, mentored 37 visiting scholars and postdocs and is currently supervising 8 PhD and 2 PharmD Honors students. Dr. Sinko is the Editor and Principal Author of the most recent edition of the textbook, Martin’s Physical Pharmacy and Pharmaceutical Sciences.
Dr. Sinko has served on many national and international scientific advisory and review panels, most notably for five years as a regular member of the Pharmacology and Xenobiotic and Nutrient Disposition and Action Study Sections of the NIH. He currently serves on a Scientific Advisory Committee for the Pharmaceutical Research and Manufacturers Association Foundation. Dr. Sinko is Section Editor for the European Journal of Pharmaceutical Sciences and is an Editorial Advisory Board member of the journals Advanced Drug Delivery Reviews, Biomedical Materials, Molecular Pharmaceutics, Recent Patents in Drug Delivery and Formulation, and Therapy. He is an active member of several professional organizations, was recently elected to the Controlled Release Society’s Board of Scientific Advisors, and is Chair of the Oral Absorption Focus group of the AAPS. Dr. Sinko serves on numerous University committees including the Executive Committee of the School of Pharmacy and a Scientific Review Panel for the Clinical and Translational Science Pilot Award program recently awarded to Rutgers University/Robert Wood Johnson Medical School by the NIH.
Dr. Sinko has broad administrative experience having held leadership positions in academia and the pharmaceutical industry. He served as Chief Scientist and Vice President for NaviCyte, Inc. and Trega BioSciences for five years (1996-2001). Dr. Sinko has also been Chair of the Department of Pharmaceutics since 1998. Immediately after assuming the leadership of the Department, he was faced with a large number of faculty retirements. Within a relatively short period of time, Dr. Sinko successfully recruited a diverse group of faculty members with the vast majority having a pharmacy background. Under his leadership, Department research funding and scholarly productivity have increased dramatically. Currently, Department faculty members have 11 NIH, 3 DOD and 3 Pharmaceutical Company grants representing $3.5 million in annual research support. Several of these faculty members have had their NIH grants renewed despite these extremely tight budget times – a testament to the high quality of their research programs. Dr. Sinko has been actively involved in a variety of curricular and strategic initiatives at Rutgers including the efforts to merge Rutgers with the University of Medicine and Dentistry of NJ. He also chaired the committee tasked with the implementation of the all-Pharm.D program in the School of Pharmacy.
Throughout his career, Dr. Sinko has received numerous awards for his research and teaching including a highly selective NIH MERIT Award in 2006 in recognition of his “paradigm shifting ideas and demonstrated outstanding productivity and superior research competence”. Fewer than 5% of NIH grantees receive these awards.
|
|
